Home
About us
About ISR
Management
Board of Directors
Technology
Technology
Intellectual Property
Pipeline
Market
HIV
Cancer
HBV
Media room
Press releases
In media
Presentations and analysis
Video
Event calender
Investor Relations
Financial calender
Financial Reports
Corporate Governance
Largest shareholders
Certified Adviser
Share Issues
Contact
Home
About us
About ISR
Management
Board of Directors
Technology
Technology
Intellectual Property
Pipeline
Market
HIV
Cancer
HBV
Media room
Press releases
In media
Presentations and analysis
Video
Event calender
Investor Relations
Financial calender
Financial Reports
Corporate Governance
Largest shareholders
Certified Adviser
Share Issues
Contact
Pipeline
HIV Indication - Phase IIa – ISR 48 (Recruiting)
HIV ART (1) resistance - Phase IIa – ISR 48 (Initiated)
HIV Indication (2) - Phase IIb/III pivotal – ISR 48 (Planned)
IND development Immunolide
Oncology - ISR 50
HBV - ISR 51
Start typing and press Enter to search
